SEC Tracker
Get the app

Jeggle Helmut Wolfgang

Bambusa Therapeutics, Inc. reports ownership

Helmut Wolfgang Jeggle, new insider at Bambusa Therapeutics, Inc.

Form
3
Filed
Importance
Routine
  1. 4,119,600 common shares held indirectly
  2. 3,135,066 Series Seed Preferred Stock
  3. 1,473,775 Series A-1 Preferred Stock
  4. 160,860 Series A-2 Preferred Stock

Written from the Form 3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Jeggle Helmut Wolfgang files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.